Skip to content
ES
MARKETS / NASDAQ / FTLF
NASDAQ · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP

Fitlife Brands, Inc. FTLF

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$81.5M
▲ 26.4% YoY
$6.3M
▼ 29.6% YoY
$7.4M
▼ 22.9% YoY
In brief

What this company does

FitLife Brands is headquartered in Omaha, Nebraska, and its common stock trades under the symbol "FTLF" on the Nasdaq Capital Market. On August 8, 2025, the Company acquired substantially all of the assets and assumed certain liabilities of Irwin Naturals and its related affiliates through an asset purchase transaction under Section 363 of the U.S. Bankruptcy Code, adding a company founded in 1994 that develops, markets, and distributes branded nutritional supplements and wellness products. Founded in 1994, Irwin offers a broad portfolio of products across multiple categories, including weight loss, sexual wellness, and body cleanse. The Company had 81 and 39 full-time employees as of December 31, 2025 and 2024, respectively, with the increase principally attributable to the acquisition of Irwin.

Written from the business description in FITLIFE BRANDS, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 31 March 2026. Every sentence was checked against that document before publication.

Growth
USD 81.5M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 81.5 · Net income 6.3
40M80M201020122014201620182020202220242025
Compound annual growth
+41.4%
+29.8%
+16.3%
+16.6%
+12.6%
−6.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +29.8% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
8 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 12.4% · Net 7.8%
10%20%30%-20%-40%201020122014201620182020202220242025
ROE
FY2025 · ROE 15.9%
50%100%-50%-100%201020122014201620182020202220242025
Gross margin38.6%
Operating margin12.4%
Net margin7.8%
Return on assets7.7%
EBITDAUSD 10.5M

Each USD of equity produced 16 cents of profit this year.

Cash & shareholders
—
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 7.4
4M8M-1M-2M201020122014201620182020202220242025
Net buybacks $M Dividends $M
FY2023 · Dividends — · Net buybacks -0.2
0.8M2014201520162017201820192020202120222023
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—

Total assetsUSD 106.3M
EquityUSD 43.6M
Current ratio1.53×

Equity funds 41% of total assets.

The 16-year record
16 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B0.00.00.00.00.00.00.00.0−0.00.0−0.00.00.00.00.0−0.0
EBITDA $B0.00.00.00.00.00.00.00.0−0.00.0−0.00.00.00.00.0·
Income tax $B0.00.00.00.00.0−0.00.00.00.00.00.00.00.0−0.00.00.0
Net income $B0.00.00.00.00.00.00.00.00.00.0−0.00.00.00.00.0−0.0
Free cash flow $B0.00.00.00.0···0.00.00.0−0.00.0··0.0−0.0
EPS, diluted $0.630.910.540.891.137.762.330.37−0.930.04−0.130.200.140.030.00−0.05
Dividend / sh $················
Payout %·····020········
ROE %15.928.421.922.937.0118.1100.333.555.86.7−13.929.024.456.010.6−106.6
Shares out B0.010.010.010.000.000.000.000.000.010.010.010.010.010.070.070.07

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 79 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 16 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onNASDAQ
Incorporated inNevada
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image